nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA9—cochlea—hypothyroidism	0.081	0.201	CbGeAlD
Galantamine—CHRFAM7A—corpus luteum—hypothyroidism	0.0359	0.0891	CbGeAlD
Galantamine—CHRNA7—corpus luteum—hypothyroidism	0.029	0.0719	CbGeAlD
Galantamine—Retching—Dextrothyroxine—hypothyroidism	0.0206	0.0524	CcSEcCtD
Galantamine—Retching—Levothyroxine—hypothyroidism	0.0206	0.0524	CcSEcCtD
Galantamine—CHRNG—tongue—hypothyroidism	0.0166	0.0411	CbGeAlD
Galantamine—CHRNA4—cochlea—hypothyroidism	0.0161	0.0398	CbGeAlD
Galantamine—Retching—Liotrix—hypothyroidism	0.0152	0.0386	CcSEcCtD
Galantamine—CHRNA1—tongue—hypothyroidism	0.011	0.0272	CbGeAlD
Galantamine—CHRNE—pituitary gland—hypothyroidism	0.0105	0.0261	CbGeAlD
Galantamine—CHRNE—blood—hypothyroidism	0.00941	0.0233	CbGeAlD
Galantamine—CHRNE—testis—hypothyroidism	0.00778	0.0193	CbGeAlD
Galantamine—Coagulopathy—Liotrix—hypothyroidism	0.00665	0.0169	CcSEcCtD
Galantamine—CHRNA4—nerve—hypothyroidism	0.00646	0.016	CbGeAlD
Galantamine—Arrhythmia—Liothyronine—hypothyroidism	0.00643	0.0164	CcSEcCtD
Galantamine—CHRNA5—thyroid gland—hypothyroidism	0.00635	0.0157	CbGeAlD
Galantamine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00614	0.0156	CcSEcCtD
Galantamine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00614	0.0156	CcSEcCtD
Galantamine—CHRNA5—testis—hypothyroidism	0.00544	0.0135	CbGeAlD
Galantamine—Hypertension—Liothyronine—hypothyroidism	0.00541	0.0138	CcSEcCtD
Galantamine—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00524	0.0133	CcSEcCtD
Galantamine—Cardiac failure—Levothyroxine—hypothyroidism	0.00524	0.0133	CcSEcCtD
Galantamine—CHRNA9—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.005	0.0245	CbGpPWpGaD
Galantamine—CHRND—heart—hypothyroidism	0.005	0.0124	CbGeAlD
Galantamine—Tachycardia—Liothyronine—hypothyroidism	0.00499	0.0127	CcSEcCtD
Galantamine—Blood urea increased—Liotrix—hypothyroidism	0.00489	0.0124	CcSEcCtD
Galantamine—Hypotension—Liothyronine—hypothyroidism	0.00478	0.0122	CcSEcCtD
Galantamine—ACHE—Monoamine Transport—SLC5A7—hypothyroidism	0.00476	0.0233	CbGpPWpGaD
Galantamine—Dehydration—Dextrothyroxine—hypothyroidism	0.00475	0.0121	CcSEcCtD
Galantamine—Dehydration—Levothyroxine—hypothyroidism	0.00475	0.0121	CcSEcCtD
Galantamine—CHRND—cardiovascular system—hypothyroidism	0.00472	0.0117	CbGeAlD
Galantamine—CHRNG—blood—hypothyroidism	0.0047	0.0117	CbGeAlD
Galantamine—CHRNB3—cerebellum—hypothyroidism	0.00456	0.0113	CbGeAlD
Galantamine—CHRNB4—adrenal gland—hypothyroidism	0.00453	0.0112	CbGeAlD
Galantamine—Hyperkinesia—Liotrix—hypothyroidism	0.00452	0.0115	CcSEcCtD
Galantamine—Muscular weakness—Levothyroxine—hypothyroidism	0.00451	0.0115	CcSEcCtD
Galantamine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00451	0.0115	CcSEcCtD
Galantamine—Dysphagia—Levothyroxine—hypothyroidism	0.00442	0.0112	CcSEcCtD
Galantamine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00442	0.0112	CcSEcCtD
Galantamine—CHRNB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00437	0.0214	CbGpPWpGaD
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00429	0.021	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00414	0.0203	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00414	0.0203	CbGpPWpGaD
Galantamine—Body temperature increased—Liothyronine—hypothyroidism	0.00404	0.0103	CcSEcCtD
Galantamine—Weight decreased—Levothyroxine—hypothyroidism	0.004	0.0102	CcSEcCtD
Galantamine—Weight decreased—Dextrothyroxine—hypothyroidism	0.004	0.0102	CcSEcCtD
Galantamine—CHRNA10—blood—hypothyroidism	0.00399	0.00988	CbGeAlD
Galantamine—CHRNB2—adrenal cortex—hypothyroidism	0.00397	0.00984	CbGeAlD
Galantamine—CHRNG—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00395	0.0194	CbGpPWpGaD
Galantamine—Renal impairment—Liotrix—hypothyroidism	0.00395	0.0101	CcSEcCtD
Galantamine—Cardiac failure—Liotrix—hypothyroidism	0.00385	0.0098	CcSEcCtD
Galantamine—CHRNB2—heart—hypothyroidism	0.00384	0.00952	CbGeAlD
Galantamine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00384	0.00976	CcSEcCtD
Galantamine—CHRNA9—Neuronal System—SLC5A7—hypothyroidism	0.00383	0.0188	CbGpPWpGaD
Galantamine—CHRNA6—cerebellum—hypothyroidism	0.00381	0.00945	CbGeAlD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00375	0.0184	CbGpPWpGaD
Galantamine—CHRNB4—testis—hypothyroidism	0.00375	0.00929	CbGeAlD
Galantamine—CHRNE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00372	0.0182	CbGpPWpGaD
Galantamine—CYP3A4—urine—hypothyroidism	0.00361	0.00894	CbGeAlD
Galantamine—CHRND—thyroid gland—hypothyroidism	0.0036	0.00892	CbGeAlD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00355	0.0174	CbGpPWpGaD
Galantamine—CYP2D6—urine—hypothyroidism	0.00355	0.0088	CbGeAlD
Galantamine—Dehydration—Liotrix—hypothyroidism	0.0035	0.0089	CcSEcCtD
Galantamine—CHRNA2—heart—hypothyroidism	0.00346	0.00858	CbGeAlD
Galantamine—Hypokalaemia—Liotrix—hypothyroidism	0.00342	0.00871	CcSEcCtD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00339	0.0166	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—SLC5A7—hypothyroidism	0.00335	0.0164	CbGpPWpGaD
Galantamine—Muscular weakness—Liotrix—hypothyroidism	0.00331	0.00844	CcSEcCtD
Galantamine—CHRNA10—testis—hypothyroidism	0.0033	0.00818	CbGeAlD
Galantamine—Flushing—Levothyroxine—hypothyroidism	0.00328	0.00835	CcSEcCtD
Galantamine—Flushing—Dextrothyroxine—hypothyroidism	0.00328	0.00835	CcSEcCtD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00326	0.016	CbGpPWpGaD
Galantamine—Dysphagia—Liotrix—hypothyroidism	0.00325	0.00827	CcSEcCtD
Galantamine—CHRNA9—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00322	0.0158	CbGpPWpGaD
Galantamine—CHRNB1—heart—hypothyroidism	0.00322	0.00798	CbGeAlD
Galantamine—CHRNB2—pituitary gland—hypothyroidism	0.00321	0.00795	CbGeAlD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00319	0.0156	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—SLC5A7—hypothyroidism	0.00317	0.0156	CbGpPWpGaD
Galantamine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00316	0.00804	CcSEcCtD
Galantamine—Arrhythmia—Levothyroxine—hypothyroidism	0.00316	0.00804	CcSEcCtD
Galantamine—CHRNA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00314	0.0154	CbGpPWpGaD
Galantamine—Bronchitis—Liotrix—hypothyroidism	0.00312	0.00795	CcSEcCtD
Galantamine—CHRNG—Neuronal System—SLC5A7—hypothyroidism	0.00303	0.0149	CbGpPWpGaD
Galantamine—Tension—Levothyroxine—hypothyroidism	0.00302	0.00769	CcSEcCtD
Galantamine—Tension—Dextrothyroxine—hypothyroidism	0.00302	0.00769	CcSEcCtD
Galantamine—CHRNA1—thyroid gland—hypothyroidism	0.003	0.00745	CbGeAlD
Galantamine—Nervousness—Levothyroxine—hypothyroidism	0.00299	0.00761	CcSEcCtD
Galantamine—Nervousness—Dextrothyroxine—hypothyroidism	0.00299	0.00761	CcSEcCtD
Galantamine—Weight decreased—Liotrix—hypothyroidism	0.00294	0.00748	CcSEcCtD
Galantamine—Tremor—Levothyroxine—hypothyroidism	0.00288	0.00734	CcSEcCtD
Galantamine—Tremor—Dextrothyroxine—hypothyroidism	0.00288	0.00734	CcSEcCtD
Galantamine—CHRNB2—adrenal gland—hypothyroidism	0.00286	0.0071	CbGeAlD
Galantamine—CHRNB2—blood—hypothyroidism	0.00286	0.0071	CbGeAlD
Galantamine—Renal failure—Liotrix—hypothyroidism	0.00285	0.00725	CcSEcCtD
Galantamine—CHRNE—Neuronal System—SLC5A7—hypothyroidism	0.00285	0.014	CbGpPWpGaD
Galantamine—Agitation—Levothyroxine—hypothyroidism	0.00283	0.0072	CcSEcCtD
Galantamine—Agitation—Dextrothyroxine—hypothyroidism	0.00283	0.0072	CcSEcCtD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00283	0.0139	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00282	0.0138	CbGpPWpGaD
Galantamine—ACHE—heart—hypothyroidism	0.00279	0.00692	CbGeAlD
Galantamine—CHRNA3—adrenal gland—hypothyroidism	0.00278	0.00689	CbGeAlD
Galantamine—CHRNB2—thyroid gland—hypothyroidism	0.00276	0.00685	CbGeAlD
Galantamine—CHRNB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00276	0.0136	CbGpPWpGaD
Galantamine—Palpitations—Levothyroxine—hypothyroidism	0.00272	0.00692	CcSEcCtD
Galantamine—Palpitations—Dextrothyroxine—hypothyroidism	0.00272	0.00692	CcSEcCtD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00269	0.0132	CbGpPWpGaD
Galantamine—CHRNB2—female gonad—hypothyroidism	0.00267	0.00662	CbGeAlD
Galantamine—CHRNA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00267	0.0131	CbGpPWpGaD
Galantamine—Convulsion—Levothyroxine—hypothyroidism	0.00267	0.00679	CcSEcCtD
Galantamine—Convulsion—Dextrothyroxine—hypothyroidism	0.00267	0.00679	CcSEcCtD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00267	0.0131	CbGpPWpGaD
Galantamine—Arthralgia—Dextrothyroxine—hypothyroidism	0.00262	0.00667	CcSEcCtD
Galantamine—Arthralgia—Levothyroxine—hypothyroidism	0.00262	0.00667	CcSEcCtD
Galantamine—Anxiety—Dextrothyroxine—hypothyroidism	0.00261	0.00665	CcSEcCtD
Galantamine—Anxiety—Levothyroxine—hypothyroidism	0.00261	0.00665	CcSEcCtD
Galantamine—CHRNA2—blood—hypothyroidism	0.00258	0.0064	CbGeAlD
Galantamine—CHRNG—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00255	0.0125	CbGpPWpGaD
Galantamine—Confusional state—Dextrothyroxine—hypothyroidism	0.00253	0.00645	CcSEcCtD
Galantamine—Confusional state—Levothyroxine—hypothyroidism	0.00253	0.00645	CcSEcCtD
Galantamine—CHRNA2—thyroid gland—hypothyroidism	0.00249	0.00618	CbGeAlD
Galantamine—Shock—Levothyroxine—hypothyroidism	0.00247	0.00629	CcSEcCtD
Galantamine—Shock—Dextrothyroxine—hypothyroidism	0.00247	0.00629	CcSEcCtD
Galantamine—CHRNA9—Neuronal System—NEFL—hypothyroidism	0.00247	0.0121	CbGpPWpGaD
Galantamine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00245	0.00624	CcSEcCtD
Galantamine—Tachycardia—Levothyroxine—hypothyroidism	0.00245	0.00624	CcSEcCtD
Galantamine—CHRNA7—heart—hypothyroidism	0.00243	0.00603	CbGeAlD
Galantamine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00243	0.00618	CcSEcCtD
Galantamine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00243	0.00618	CcSEcCtD
Galantamine—Flushing—Liotrix—hypothyroidism	0.00241	0.00614	CcSEcCtD
Galantamine—CHRNA6—Neuronal System—SLC5A7—hypothyroidism	0.00241	0.0118	CbGpPWpGaD
Galantamine—CHRNB1—adrenal gland—hypothyroidism	0.0024	0.00596	CbGeAlD
Galantamine—CHRNB1—blood—hypothyroidism	0.0024	0.00596	CbGeAlD
Galantamine—CHRNE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00239	0.0117	CbGpPWpGaD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00237	0.0116	CbGpPWpGaD
Galantamine—CHRNB2—testis—hypothyroidism	0.00237	0.00587	CbGeAlD
Galantamine—Arrhythmia—Liotrix—hypothyroidism	0.00232	0.00591	CcSEcCtD
Galantamine—CHRNB1—thyroid gland—hypothyroidism	0.00232	0.00575	CbGeAlD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0023	0.0113	CbGpPWpGaD
Galantamine—CHRNA3—testis—hypothyroidism	0.0023	0.0057	CbGeAlD
Galantamine—CHRNA7—cardiovascular system—hypothyroidism	0.00229	0.00569	CbGeAlD
Galantamine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00229	0.00582	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00229	0.00582	CcSEcCtD
Galantamine—CHRNB2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00228	0.0112	CbGpPWpGaD
Galantamine—Insomnia—Levothyroxine—hypothyroidism	0.00227	0.00578	CcSEcCtD
Galantamine—Insomnia—Dextrothyroxine—hypothyroidism	0.00227	0.00578	CcSEcCtD
Galantamine—CHRNA4—cardiovascular system—hypothyroidism	0.00226	0.00561	CbGeAlD
Galantamine—CHRFAM7A—blood—hypothyroidism	0.00225	0.00557	CbGeAlD
Galantamine—CHRNB1—female gonad—hypothyroidism	0.00224	0.00556	CbGeAlD
Galantamine—CHRNB2—liver—hypothyroidism	0.00224	0.00555	CbGeAlD
Galantamine—Flatulence—Liotrix—hypothyroidism	0.00223	0.00568	CcSEcCtD
Galantamine—Tension—Liotrix—hypothyroidism	0.00222	0.00565	CcSEcCtD
Galantamine—Dysgeusia—Liotrix—hypothyroidism	0.00222	0.00564	CcSEcCtD
Galantamine—CHRND—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0022	0.0108	CbGpPWpGaD
Galantamine—Nervousness—Liotrix—hypothyroidism	0.0022	0.0056	CcSEcCtD
Galantamine—CHRNB2—cerebellum—hypothyroidism	0.00219	0.00543	CbGeAlD
Galantamine—CHRNB4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00218	0.0107	CbGpPWpGaD
Galantamine—CHRFAM7A—thyroid gland—hypothyroidism	0.00217	0.00538	CbGeAlD
Galantamine—Fatigue—Levothyroxine—hypothyroidism	0.00217	0.00551	CcSEcCtD
Galantamine—Fatigue—Dextrothyroxine—hypothyroidism	0.00217	0.00551	CcSEcCtD
Galantamine—CHRNB3—Neuronal System—NEFL—hypothyroidism	0.00216	0.0106	CbGpPWpGaD
Galantamine—Vision blurred—Liotrix—hypothyroidism	0.00213	0.00543	CcSEcCtD
Galantamine—CHRNA3—cerebellum—hypothyroidism	0.00212	0.00526	CbGeAlD
Galantamine—Tremor—Liotrix—hypothyroidism	0.00212	0.0054	CcSEcCtD
Galantamine—CHRNB2—Neuronal System—SLC5A7—hypothyroidism	0.00212	0.0104	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0021	0.0103	CbGpPWpGaD
Galantamine—CHRFAM7A—female gonad—hypothyroidism	0.0021	0.00519	CbGeAlD
Galantamine—ACHE—adrenal gland—hypothyroidism	0.00208	0.00517	CbGeAlD
Galantamine—Agitation—Liotrix—hypothyroidism	0.00208	0.00529	CcSEcCtD
Galantamine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00207	0.00527	CcSEcCtD
Galantamine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00207	0.00527	CcSEcCtD
Galantamine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00205	0.00523	CcSEcCtD
Galantamine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00205	0.00523	CcSEcCtD
Galantamine—CHRNA5—Neuronal System—NEFL—hypothyroidism	0.00205	0.01	CbGpPWpGaD
Galantamine—Syncope—Liotrix—hypothyroidism	0.00203	0.00517	CcSEcCtD
Galantamine—CHRNA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00202	0.00992	CbGpPWpGaD
Galantamine—ACHE—thyroid gland—hypothyroidism	0.00201	0.00499	CbGeAlD
Galantamine—Palpitations—Liotrix—hypothyroidism	0.002	0.00509	CcSEcCtD
Galantamine—CHRNA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00199	0.00976	CbGpPWpGaD
Galantamine—Loss of consciousness—Liotrix—hypothyroidism	0.00199	0.00506	CcSEcCtD
Galantamine—CHRNB1—testis—hypothyroidism	0.00199	0.00493	CbGeAlD
Galantamine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00199	0.00505	CcSEcCtD
Galantamine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00199	0.00505	CcSEcCtD
Galantamine—Abdominal pain—Levothyroxine—hypothyroidism	0.00199	0.00505	CcSEcCtD
Galantamine—Body temperature increased—Levothyroxine—hypothyroidism	0.00199	0.00505	CcSEcCtD
Galantamine—CHRNA2—cerebellum—hypothyroidism	0.00197	0.00489	CbGeAlD
Galantamine—Convulsion—Liotrix—hypothyroidism	0.00196	0.00499	CcSEcCtD
Galantamine—Hypertension—Liotrix—hypothyroidism	0.00195	0.00497	CcSEcCtD
Galantamine—CHRNG—Neuronal System—NEFL—hypothyroidism	0.00195	0.00957	CbGpPWpGaD
Galantamine—Arthralgia—Liotrix—hypothyroidism	0.00193	0.00491	CcSEcCtD
Galantamine—Chest pain—Liotrix—hypothyroidism	0.00193	0.00491	CcSEcCtD
Galantamine—Anxiety—Liotrix—hypothyroidism	0.00192	0.00489	CcSEcCtD
Galantamine—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00189	0.00926	CbGpPWpGaD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00188	0.00924	CbGpPWpGaD
Galantamine—CHRNB1—liver—hypothyroidism	0.00188	0.00466	CbGeAlD
Galantamine—CHRNA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00187	0.00917	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00187	0.00915	CbGpPWpGaD
Galantamine—Confusional state—Liotrix—hypothyroidism	0.00186	0.00474	CcSEcCtD
Galantamine—CHRFAM7A—testis—hypothyroidism	0.00186	0.00461	CbGeAlD
Galantamine—CHRNB1—cerebellum—hypothyroidism	0.00184	0.00455	CbGeAlD
Galantamine—CHRNE—Neuronal System—NEFL—hypothyroidism	0.00183	0.009	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00182	0.00893	CbGpPWpGaD
Galantamine—Shock—Liotrix—hypothyroidism	0.00182	0.00463	CcSEcCtD
Galantamine—CHRNA7—adrenal gland—hypothyroidism	0.00181	0.0045	CbGeAlD
Galantamine—CHRNA7—blood—hypothyroidism	0.00181	0.0045	CbGeAlD
Galantamine—Tachycardia—Liotrix—hypothyroidism	0.0018	0.00459	CcSEcCtD
Galantamine—Asthenia—Levothyroxine—hypothyroidism	0.0018	0.00459	CcSEcCtD
Galantamine—Asthenia—Dextrothyroxine—hypothyroidism	0.0018	0.00459	CcSEcCtD
Galantamine—CHRNA4—adrenal gland—hypothyroidism	0.00179	0.00444	CbGeAlD
Galantamine—Hyperhidrosis—Liotrix—hypothyroidism	0.00179	0.00455	CcSEcCtD
Galantamine—CHRNB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00178	0.00874	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00178	0.00871	CbGpPWpGaD
Galantamine—Anorexia—Liotrix—hypothyroidism	0.00176	0.00448	CcSEcCtD
Galantamine—CHRNA7—thyroid gland—hypothyroidism	0.00175	0.00434	CbGeAlD
Galantamine—Hypotension—Liotrix—hypothyroidism	0.00173	0.00439	CcSEcCtD
Galantamine—ACHE—testis—hypothyroidism	0.00172	0.00427	CbGeAlD
Galantamine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00172	0.00437	CcSEcCtD
Galantamine—Diarrhoea—Levothyroxine—hypothyroidism	0.00172	0.00437	CcSEcCtD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00171	0.00837	CbGpPWpGaD
Galantamine—CHRNA7—female gonad—hypothyroidism	0.00169	0.0042	CbGeAlD
Galantamine—CHRND—Neuronal System—SLC5A7—hypothyroidism	0.00168	0.00826	CbGpPWpGaD
Galantamine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00168	0.00428	CcSEcCtD
Galantamine—Insomnia—Liotrix—hypothyroidism	0.00167	0.00425	CcSEcCtD
Galantamine—CHRNB4—Neuronal System—SLC5A7—hypothyroidism	0.00167	0.00818	CbGpPWpGaD
Galantamine—Paraesthesia—Liotrix—hypothyroidism	0.00166	0.00422	CcSEcCtD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00162	0.00794	CbGpPWpGaD
Galantamine—Decreased appetite—Liotrix—hypothyroidism	0.00161	0.00409	CcSEcCtD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0016	0.00786	CbGpPWpGaD
Galantamine—Vomiting—Levothyroxine—hypothyroidism	0.0016	0.00406	CcSEcCtD
Galantamine—Vomiting—Dextrothyroxine—hypothyroidism	0.0016	0.00406	CcSEcCtD
Galantamine—Fatigue—Liotrix—hypothyroidism	0.00159	0.00405	CcSEcCtD
Galantamine—ACHE—cerebellum—hypothyroidism	0.00159	0.00395	CbGeAlD
Galantamine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00159	0.00779	CbGpPWpGaD
Galantamine—Rash—Dextrothyroxine—hypothyroidism	0.00158	0.00403	CcSEcCtD
Galantamine—Rash—Levothyroxine—hypothyroidism	0.00158	0.00403	CcSEcCtD
Galantamine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00158	0.00403	CcSEcCtD
Galantamine—Dermatitis—Levothyroxine—hypothyroidism	0.00158	0.00403	CcSEcCtD
Galantamine—Constipation—Liotrix—hypothyroidism	0.00158	0.00402	CcSEcCtD
Galantamine—Headache—Dextrothyroxine—hypothyroidism	0.00157	0.004	CcSEcCtD
Galantamine—Headache—Levothyroxine—hypothyroidism	0.00157	0.004	CcSEcCtD
Galantamine—CHRNA6—Neuronal System—NEFL—hypothyroidism	0.00155	0.0076	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00154	0.00755	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—SLC5A7—hypothyroidism	0.00152	0.00748	CbGpPWpGaD
Galantamine—Feeling abnormal—Liotrix—hypothyroidism	0.00152	0.00387	CcSEcCtD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00152	0.00747	CbGpPWpGaD
Galantamine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00151	0.00385	CcSEcCtD
Galantamine—CHRNA7—testis—hypothyroidism	0.0015	0.00372	CbGeAlD
Galantamine—Nausea—Dextrothyroxine—hypothyroidism	0.00149	0.0038	CcSEcCtD
Galantamine—Nausea—Levothyroxine—hypothyroidism	0.00149	0.0038	CcSEcCtD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00148	0.00728	CbGpPWpGaD
Galantamine—Abdominal pain—Liotrix—hypothyroidism	0.00146	0.00372	CcSEcCtD
Galantamine—Body temperature increased—Liotrix—hypothyroidism	0.00146	0.00372	CcSEcCtD
Galantamine—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00145	0.0071	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—SLC5A7—hypothyroidism	0.00143	0.00702	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00142	0.00695	CbGpPWpGaD
Galantamine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00142	0.00695	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0014	0.00688	CbGpPWpGaD
Galantamine—BCHE—heart—hypothyroidism	0.00137	0.0034	CbGeAlD
Galantamine—CHRNA4—cerebellum—hypothyroidism	0.00137	0.00339	CbGeAlD
Galantamine—CHRNB2—Neuronal System—NEFL—hypothyroidism	0.00136	0.00669	CbGpPWpGaD
Galantamine—Hypersensitivity—Liotrix—hypothyroidism	0.00136	0.00346	CcSEcCtD
Galantamine—CHRNA2—Neuronal System—SLC5A7—hypothyroidism	0.00136	0.00667	CbGpPWpGaD
Galantamine—Asthenia—Liotrix—hypothyroidism	0.00133	0.00337	CcSEcCtD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00132	0.00647	CbGpPWpGaD
Galantamine—BCHE—cardiovascular system—hypothyroidism	0.00129	0.00321	CbGeAlD
Galantamine—CHRNA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00128	0.00629	CbGpPWpGaD
Galantamine—Diarrhoea—Liotrix—hypothyroidism	0.00126	0.00322	CcSEcCtD
Galantamine—Dizziness—Liotrix—hypothyroidism	0.00122	0.00311	CcSEcCtD
Galantamine—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00122	0.00597	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0012	0.00591	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.00118	0.00579	CbGpPWpGaD
Galantamine—Vomiting—Liotrix—hypothyroidism	0.00117	0.00299	CcSEcCtD
Galantamine—Rash—Liotrix—hypothyroidism	0.00116	0.00296	CcSEcCtD
Galantamine—Dermatitis—Liotrix—hypothyroidism	0.00116	0.00296	CcSEcCtD
Galantamine—ACHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00116	0.0057	CbGpPWpGaD
Galantamine—Headache—Liotrix—hypothyroidism	0.00116	0.00295	CcSEcCtD
Galantamine—BCHE—pituitary gland—hypothyroidism	0.00115	0.00284	CbGeAlD
Galantamine—CHRNA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00114	0.00561	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0011	0.00539	CbGpPWpGaD
Galantamine—Nausea—Liotrix—hypothyroidism	0.0011	0.00279	CcSEcCtD
Galantamine—CHRND—Neuronal System—NEFL—hypothyroidism	0.00109	0.00532	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—NEFL—hypothyroidism	0.00107	0.00527	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00106	0.0052	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00104	0.00509	CbGpPWpGaD
Galantamine—BCHE—adrenal gland—hypothyroidism	0.00102	0.00254	CbGeAlD
Galantamine—BCHE—blood—hypothyroidism	0.00102	0.00254	CbGeAlD
Galantamine—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000992	0.00487	CbGpPWpGaD
Galantamine—BCHE—thyroid gland—hypothyroidism	0.000988	0.00245	CbGeAlD
Galantamine—CHRNA3—Neuronal System—NEFL—hypothyroidism	0.000983	0.00482	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00098	0.00481	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.000933	0.00457	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—NEFL—hypothyroidism	0.000923	0.00453	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—NEFL—hypothyroidism	0.000877	0.0043	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—AVP—hypothyroidism	0.000866	0.00425	CbGpPWpGaD
Galantamine—BCHE—testis—hypothyroidism	0.000847	0.0021	CbGeAlD
Galantamine—ACHE—Neuronal System—SLC5A7—hypothyroidism	0.000842	0.00413	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000835	0.0041	CbGpPWpGaD
Galantamine—BCHE—liver—hypothyroidism	0.000801	0.00199	CbGeAlD
Galantamine—BCHE—cerebellum—hypothyroidism	0.000782	0.00194	CbGeAlD
Galantamine—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.00076	0.00373	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—SLC5A7—hypothyroidism	0.000751	0.00368	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000725	0.00356	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000708	0.00347	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000703	0.00345	CbGpPWpGaD
Galantamine—CYP3A4—blood—hypothyroidism	0.000689	0.00171	CbGeAlD
Galantamine—CYP2D6—blood—hypothyroidism	0.000678	0.00168	CbGeAlD
Galantamine—CYP2D6—female gonad—hypothyroidism	0.000633	0.00157	CbGeAlD
Galantamine—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000631	0.0031	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000628	0.00308	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000591	0.0029	CbGpPWpGaD
Galantamine—CYP2D6—testis—hypothyroidism	0.000561	0.00139	CbGeAlD
Galantamine—ACHE—Neuronal System—NEFL—hypothyroidism	0.000542	0.00266	CbGpPWpGaD
Galantamine—CYP3A4—liver—hypothyroidism	0.000539	0.00134	CbGeAlD
Galantamine—CYP2D6—liver—hypothyroidism	0.00053	0.00132	CbGeAlD
Galantamine—CYP2D6—cerebellum—hypothyroidism	0.000518	0.00128	CbGeAlD
Galantamine—BCHE—Neuronal System—NEFL—hypothyroidism	0.000484	0.00237	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000455	0.00223	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000438	0.00215	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000406	0.00199	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000391	0.00192	CbGpPWpGaD
Galantamine—ACHE—Metabolism—IYD—hypothyroidism	0.000306	0.0015	CbGpPWpGaD
Galantamine—BCHE—Metabolism—IYD—hypothyroidism	0.000273	0.00134	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ATP5O—hypothyroidism	0.00026	0.00128	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000247	0.00121	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TPO—hypothyroidism	0.000244	0.0012	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ATP5O—hypothyroidism	0.000232	0.00114	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000229	0.00112	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000226	0.00111	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—TSHB—hypothyroidism	0.00022	0.00108	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TPO—hypothyroidism	0.000218	0.00107	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000202	0.000991	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.0002	0.000982	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—TSHB—hypothyroidism	0.000196	0.000961	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000161	0.000792	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000131	0.000642	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IYD—hypothyroidism	0.000125	0.000615	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TSHB—hypothyroidism	0.000113	0.000555	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000107	0.000523	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000106	0.000521	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TSHB—hypothyroidism	0.000101	0.000495	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3C2A—hypothyroidism	0.000101	0.000495	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TPO—hypothyroidism	0.0001	0.000492	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	9.95e-05	0.000488	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3C2A—hypothyroidism	9e-05	0.000441	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.88e-05	0.000435	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—hypothyroidism	8.6e-05	0.000422	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC5A5—hypothyroidism	8.47e-05	0.000416	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—hypothyroidism	8.27e-05	0.000406	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IYD—hypothyroidism	8.2e-05	0.000402	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—hypothyroidism	7.67e-05	0.000376	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A5—hypothyroidism	7.56e-05	0.000371	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—hypothyroidism	7.38e-05	0.000362	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.97e-05	0.000342	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.95e-05	0.000341	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TPO—hypothyroidism	6.55e-05	0.000322	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TSHB—hypothyroidism	4.64e-05	0.000228	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—hypothyroidism	4.43e-05	0.000217	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.14e-05	0.000203	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—hypothyroidism	3.95e-05	0.000194	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.47e-05	0.00017	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TSHB—hypothyroidism	3.03e-05	0.000149	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.7e-05	0.000133	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.27e-05	0.000111	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—hypothyroidism	1.82e-05	8.92e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—hypothyroidism	1.19e-05	5.83e-05	CbGpPWpGaD
